{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:37:00Z","timestamp":1793399820190,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100015223","name":"Danish Diabetes and Endocrine Academy","doi-asserted-by":"publisher","award":["NNF22SA0079901"],"award-info":[{"award-number":["NNF22SA0079901"]}],"id":[{"id":"10.13039\/100015223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006304","name":"Aalborg University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006304","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00198-026-07850-9","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:17:49Z","timestamp":1769005069000},"page":"703-716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Profiling bone status indices reveals evidence of a low-turnover bone phenotype in type 2 diabetes: findings from the DiaFALL cohort"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3880-3058","authenticated-orcid":false,"given":"Nicklas H.","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika Vestergaard","family":"Kvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asger Ahlmann","family":"Bech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lykkeboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Starup-Linde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aase","family":"Handberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop P.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"7850_CR1","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2337\/db16-0063","volume":"65","author":"DE Sellmeyer","year":"2016","unstructured":"Sellmeyer DE, Civitelli R, Hofbauer LC, Khosla S, Lecka-Czernik B, Schwartz AV (2016) Skeletal metabolism, fracture risk, and fracture outcomes in type 1 and type 2 diabetes. Diabetes 65:1757\u20131766","journal-title":"Diabetes"},{"key":"7850_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3803\/EnM.2018.33.3.339","volume":"33","author":"JS Linde","year":"2018","unstructured":"Linde JS, Hygum K, Langdahl BL (2018) Skeletal fragility in type 2 diabetes mellitus. Endocrinol Metab 33:339\u2013351","journal-title":"Endocrinol Metab"},{"key":"7850_CR3","doi-asserted-by":"publisher","first-page":"101614","DOI":"10.1016\/j.bonr.2022.101614","volume":"17","author":"C Sarodnik","year":"2022","unstructured":"Sarodnik C, Rasmussen NH, Bours SPG, Schaper NC, Vestergaard P, Souverein PC, Jensen MH, Driessen JHM, van den Bergh JPW (2022) The incidence of fractures at various sites in newly treated patients with type 2 diabetes mellitus. Bone Rep 17:101614","journal-title":"Bone Rep"},{"key":"7850_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00223-016-0175-x","volume":"100","author":"J Starup-Linde","year":"2017","unstructured":"Starup-Linde J, Frost M, Vestergaard P, Abrahamsen B (2017) Epidemiology of fractures in diabetes. Calcif Tissue Int 100:109\u2013121","journal-title":"Calcif Tissue Int"},{"key":"7850_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00223-008-9195-5","volume":"84","author":"P Vestergaard","year":"2009","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2009) Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int 84:45\u201355","journal-title":"Calcif Tissue Int"},{"key":"7850_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.afos.2019.05.001","volume":"5","author":"K Hygum","year":"2019","unstructured":"Hygum K, Starup-Linde J, Langdahl BL (2019) Diabetes and bone. Osteoporos Sarcopenia 5:29\u201337","journal-title":"Osteoporos Sarcopenia"},{"key":"7850_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7608964","author":"C Eller-Vainicher","year":"2020","unstructured":"Eller-Vainicher C, Cairoli E, Grassi G, Grassi F, Catalano A, Merlotti D, Falchetti A, Gaudio A, Chiodini I, Gennari L (2020) Pathophysiology and management of type 2 diabetes mellitus bone fragility. J Diabetes Res. https:\/\/doi.org\/10.1155\/2020\/7608964","journal-title":"J Diabetes Res"},{"key":"7850_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruy\u00e8re O et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391\u2013420","journal-title":"Osteoporos Int"},{"issue":"4","key":"7850_CR9","first-page":"1","volume":"41","author":"MR Rubin","year":"2016","unstructured":"Rubin MR (2016) Patsch JM (2016) Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions. Bone Res 41(4):1\u20139","journal-title":"Bone Res"},{"key":"7850_CR10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1210\/jc.2015-3882","volume":"101","author":"J Starup-Linde","year":"2016","unstructured":"Starup-Linde J, Lykkeboe S, Gregersen S, Hauge EM, Langdahl BL, Handberg A, Vestergaard P (2016) Bone structure and predictors of fracture in type 1 and type 2 diabetes. J Clin Endocrinol Metab 101:928\u2013936","journal-title":"J Clin Endocrinol Metab"},{"key":"7850_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bone.2015.11.004","volume":"83","author":"J Starup-Linde","year":"2016","unstructured":"Starup-Linde J, Lykkeboe S, Gregersen S, Hauge EM, Langdahl BL, Handberg A, Vestergaard P (2016) Differences in biochemical bone markers by diabetes type and the impact of glucose. Bone 83:149\u2013155","journal-title":"Bone"},{"key":"7850_CR12","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s00125-023-05891-x","volume":"66","author":"A Kautzky-Willer","year":"2023","unstructured":"Kautzky-Willer A, Leutner M, Harreiter J (2023) Sex differences in type 2 diabetes. Diabetologia 66:986\u20131002","journal-title":"Diabetologia"},{"key":"7850_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/105294199277860","volume":"6","author":"JR Dixon","year":"1998","unstructured":"Dixon JR (1998) The international conference on harmonization good clinical practice guideline. Qual Assur 6:65\u201374","journal-title":"Qual Assur"},{"key":"7850_CR14","doi-asserted-by":"crossref","unstructured":"(2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191\u20132194","DOI":"10.1001\/jama.2013.281053"},{"key":"7850_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-022-01188-5","volume":"18","author":"NH-H Rasmussen","year":"2022","unstructured":"Rasmussen NH-H, Dal J, Jensen MH, Kvist AV, van den Bergh J, Hirata RP, Vestergaard P (2022) Impaired postural control in diabetes-a predictor of falls? Arch Osteoporos 18:6","journal-title":"Arch Osteoporos"},{"key":"7850_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/rpd\/ncl078","volume":"123","author":"J Brunzendorf","year":"2007","unstructured":"Brunzendorf J, Behrens R (2007) How to type test the coefficient of variation of an indication. Radiat Prot Dosimetry 123:21\u201331","journal-title":"Radiat Prot Dosimetry"},{"key":"7850_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/bs.acc.2019.01.006","volume":"90","author":"J Pum","year":"2019","unstructured":"Pum J (2019) A practical guide to validation and verification of analytical methods in the clinical laboratory. Adv Clin Chem 90:215\u2013281","journal-title":"Adv Clin Chem"},{"key":"7850_CR18","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.ejrad.2016.04.004","volume":"85","author":"A Bazzocchi","year":"2016","unstructured":"Bazzocchi A, Ponti F, Albisinni U, Battista G, Guglielmi G (2016) DXA: Technical aspects and application. Eur J Radiol 85:1481\u20131492","journal-title":"Eur J Radiol"},{"key":"7850_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jocd.2007.01.005","volume":"10","author":"AA Khan","year":"2007","unstructured":"Khan AA, Colquhoun A, Hanley DA et al (2007) Standards and guidelines for technologists performing central dual-energy X-ray absorptiometry. J Clin Densitom 10:189\u2013195","journal-title":"J Clin Densitom"},{"key":"7850_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"7850_CR21","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1515\/cclm-2024-1148","volume":"63","author":"G Lombardi","year":"2025","unstructured":"Lombardi G, J\u00f8rgensen NR, Harvey NC et al (2025) Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism. Clin Chem Lab Med 63:704\u2013711","journal-title":"Clin Chem Lab Med"},{"key":"7850_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/FPHYS.2024.1330171","author":"J Yang","year":"2024","unstructured":"Yang J, Zhang Y, Liu X, Chen B, Lei L (2024) Effect of type 2 diabetes on biochemical markers of bone metabolism: a meta-analysis. Front Physiol. https:\/\/doi.org\/10.3389\/FPHYS.2024.1330171","journal-title":"Front Physiol"},{"key":"7850_CR23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00223-022-01022-7","volume":"111","author":"J Vavanikunnel","year":"2022","unstructured":"Vavanikunnel J, Sewing L, Triantafyllidou M et al (2022) Determinants of low bone turnover in type 2 diabetes-the role of PTH. Calcif Tissue Int 111:587\u2013596","journal-title":"Calcif Tissue Int"},{"key":"7850_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2013.00021\/PDF","author":"J Starup-Linde","year":"2013","unstructured":"Starup-Linde J (2013) Diabetes, biochemical markers of bone turnover, diabetes control, and bone. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/FENDO.2013.00021\/PDF","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7850_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6191468","author":"XX Liu","year":"2020","unstructured":"Liu XX, Jiang L, Liu Q, Zhang J, Niu W, Liu J, Zhang Q (2020) Low bone turnover markers in young and middle-aged male patients with type 2 diabetes mellitus. J Diabetes Res. https:\/\/doi.org\/10.1155\/2020\/6191468","journal-title":"J Diabetes Res"},{"key":"7850_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.maturitas.2017.12.011","volume":"109","author":"C Sarodnik","year":"2018","unstructured":"Sarodnik C, Bours SPG, Schaper NC, van den Bergh JP, van Geel TACM (2018) The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus. Maturitas 109:70\u201377","journal-title":"Maturitas"},{"key":"7850_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/J.BONE.2023.116753","author":"NHhessellund Rasmussen","year":"2023","unstructured":"Rasmussen NHhessellund, Dal J, Kvist AV, van den Bergh JP, Jensen MH, Vestergaard P (2023) Bone parameters in T1D and T2D assessed by DXA and HR-pQCT - a cross-sectional study: the DIAFALL study. Bone. https:\/\/doi.org\/10.1016\/J.BONE.2023.116753","journal-title":"Bone"},{"key":"7850_CR28","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1210\/jc.2013-2143","volume":"98","author":"M Yamamoto","year":"2013","unstructured":"Yamamoto M, Yamauchi M, Sugimoto T (2013) Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 98:4030\u20134037","journal-title":"J Clin Endocrinol Metab"},{"key":"7850_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bone.2013.06.029","volume":"56","author":"MSM Ardawi","year":"2013","unstructured":"Ardawi MSM, Akhbar DH, AlShaikh A, Ahmed MM, Qari MH, Rouzi AA, Ali AY, Abdulrafee AA, Saeda MY (2013) Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Bone 56:355\u2013362","journal-title":"Bone"},{"key":"7850_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2021.649718","author":"JK Starup-Linde","year":"2021","unstructured":"Starup-Linde JK, Viggers R, Langdahl B, Gregersen S, Lykkeboe S, Handberg A, Vestergaard P (2021) Associations of circulating osteoglycin with bone parameters and metabolic markers in patients with diabetes. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/FENDO.2021.649718","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7850_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.eprac.2023.04.013","volume":"29","author":"J Buratto","year":"2023","unstructured":"Buratto J, Kirk B, Phu S, Vogrin S, Duque G (2023) Safety and efficacy of testosterone therapy on musculoskeletal health and clinical outcomes in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Endocr Pract 29:727\u2013734","journal-title":"Endocr Pract"},{"key":"7850_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/dme.13553","volume":"35","author":"M Algeffari","year":"2018","unstructured":"Algeffari M, Jayasena CN, MacKeith P, Thapar A, Dhillo WS, Oliver N (2018) Testosterone therapy for sexual dysfunction in men with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabet Med 35:195\u2013202","journal-title":"Diabet Med"},{"key":"7850_CR33","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1055\/s-0035-1564134","volume":"47","author":"C Liu","year":"2015","unstructured":"Liu C, Wo J, Zhao Q, Wang Y, Wang B, Zhao W (2015) Association between serum total osteocalcin level and type 2 diabetes mellitus: a systematic review and meta-analysis. Horm Metab Res 47:813\u2013819","journal-title":"Horm Metab Res"},{"key":"7850_CR34","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/jbmr.4330","volume":"36","author":"H Zeng","year":"2021","unstructured":"Zeng H, Ge J, Xu W, Ma H, Chen L, Xia M, Pan B, Lin H, Wang S, Gao X (2021) Type 2 diabetes is causally associated with reduced serum osteocalcin: a genomewide association and Mendelian randomization study. J Bone Miner Res 36:1694\u20131707","journal-title":"J Bone Miner Res"},{"key":"7850_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/J.CCA.2024.120067","author":"W Determe","year":"2025","unstructured":"Determe W, Hauge SC, Demeuse J et al (2025) Osteocalcin: a bone protein with multiple endocrine functions. Clin Chim Acta. https:\/\/doi.org\/10.1016\/J.CCA.2024.120067","journal-title":"Clin Chim Acta"},{"key":"7850_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/BMJOPEN-2023-075607","author":"MM Taderegew","year":"2023","unstructured":"Taderegew MM, Woldeamanuel GG, Wondie A, Getawey A, Abegaz AN, Adane F (2023) Vitamin D deficiency and its associated factors among patients with type 2 diabetes mellitus: a systematic review and meta-analysis. BMJ Open. https:\/\/doi.org\/10.1136\/BMJOPEN-2023-075607","journal-title":"BMJ Open"},{"key":"7850_CR37","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.1111\/dom.15941","volume":"26","author":"W Chen","year":"2024","unstructured":"Chen W, Liu L, Hu F (2024) Efficacy of vitamin D supplementation on glycaemic control in type 2 diabetes: an updated systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab 26:5713\u20135726","journal-title":"Diabetes Obes Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-07850-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-07850-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-07850-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:37:37Z","timestamp":1776245857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-026-07850-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7850"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-07850-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The methods used have been tested and performed in several studies both in Denmark and abroad, and no long-term side effects have been reported. The risks associated with the project are few, and the tests implied limited risks. The potential benefits in terms of well-being were considerable and estimated to outweigh the potential risks. The study was reported to the local ethical committee in the North Jutland Region (N-2019\u20130004). The study was conducted in compliance with Harmonized Tripartite Guideline for\u00a0\n                      Good Clinical Practice (\n                      ICH GCP) and applicable regulatory requirements and in accordance with the Helsinki Declaration for biomedical research involving test participants. Finally, the project was reported to the North Jutland Research department (ID-number of 2018\u2013174).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent for each participant was achieved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent for each participant was achieved.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Peter Vestergaard is head of research in the Steno Diabetes Center North Denmark, sponsored by the Novo Nordisk Foundation. Joop van den Bergh is involved in research that is sponsored by Amgen, Porous, and UCB. Jakob Starup-Linde holds lecture fees from Gedeon Richter Nordics AB and UCB Nordic A\/S. Nicklas H. Rasmussen holds shares in Novo Nordisk and a grant from DDEA. Annika Vestergaard Kvist, Asger Ahlmann Bech, Simon Lykkeboe and Aase Handberg declare that she has no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}